These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2228025)

  • 41. Adjuvant modulation of immune responses to tuberculosis subunit vaccines.
    Lindblad EB; Elhay MJ; Silva R; Appelberg R; Andersen P
    Infect Immun; 1997 Feb; 65(2):623-9. PubMed ID: 9009322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of isotype immunoglobulin production by adjuvants in vivo.
    Karagouni EE; Hadjipetrou-Kourounakis L
    Scand J Immunol; 1990 Jun; 31(6):745-54. PubMed ID: 1694039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased adjuvant efficacy in stimulation of antibody responses after macrophage elimination in vivo.
    Leenaars PP; Savelkoul HF; Hendriksen CF; Van Rooijen N; Claassen E
    Immunology; 1997 Mar; 90(3):337-43. PubMed ID: 9155638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adjuvant properties of Micropolyspora faeni.
    Bice DE; McCarron K; Hoffman EO; Salvaggio J
    Int Arch Allergy Appl Immunol; 1977; 55(1-6):267-74. PubMed ID: 338504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination.
    Zaharoff DA; Rogers CJ; Hance KW; Schlom J; Greiner JW
    Vaccine; 2007 Mar; 25(11):2085-94. PubMed ID: 17258843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immune response in the hamster. VIII. Ig class differences in susceptibility to tolerance induction.
    Portis JL; Coe JE
    J Immunol; 1976 Sep; 117(3):835-40. PubMed ID: 956656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjuvants in the induction and enhancement of rat IgE responses.
    Jarrett EE; Hall E; Karlsson T; Bennich H
    Clin Exp Immunol; 1980 Jan; 39(1):183-9. PubMed ID: 6248278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced antigen-specific responses in bovine mammary glands following administration of interleukin-2.
    Pighetti GM; Sordillo LM
    J Dairy Sci; 1995 Mar; 78(3):528-37. PubMed ID: 7782509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A clinically applicable adjuvant for an atherosclerosis vaccine in mice.
    Kobiyama K; Vassallo M; Mitzi J; Winkels H; Pei H; Kimura T; Miller J; Wolf D; Ley K
    Eur J Immunol; 2018 Sep; 48(9):1580-1587. PubMed ID: 29932463
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different stimulating effects of complement C3b and complete Freund's adjuvant on antibody response.
    Villiers MB; Villiers CL; Laharie AM; Marche PN
    Immunopharmacology; 1999 May; 42(1-3):151-7. PubMed ID: 10408375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histopathological studies on the local reactions induced by complete Freund's adjuvant (CFA), bacterial lipopolysaccharide (LPS), and synthetic lipopeptide (P3C) conjugates.
    Wiedemann F; Link R; Pumpe K; Jacobshagen U; Schaefer HE; Wiesmüller KH; Hummel RP; Jung G; Bessler W; Böltz T
    J Pathol; 1991 Jul; 164(3):265-71. PubMed ID: 1890551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunostimulatory effects of Toll-like receptor ligands as adjuvants in establishing a novel mouse model for pemphigus vulgaris.
    Gao C; Liu M; Xin Y; Zeng Y; Yang H; Fan X; Zhao C; Zhang B; Zhang L; Li JJ; Zhao M; Wang Z; Lu Q
    Clin Transl Med; 2024 Jul; 14(7):e1765. PubMed ID: 39031979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bystander activation of irrelevant CD4+ T cells following antigen-specific vaccination occurs in the presence and absence of adjuvant.
    van Aalst S; Ludwig IS; van der Zee R; van Eden W; Broere F
    PLoS One; 2017; 12(5):e0177365. PubMed ID: 28489886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gliding bacterial adjuvant stimulates feline cytokines in vitro and antigen-specific IgG in vivo.
    Zeidner NS; Belasco DL; Dreitz MJ; Frank GR; Usinger WR
    Vaccine; 1995 Oct; 13(14):1294-9. PubMed ID: 8585283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The antibody-containing cell response in hepatic and intestinal lymph following intraperitoneal and intravenous administration of antigen in different adjuvants.
    Beh KJ; Lascelles AK
    Vet Immunol Immunopathol; 1983 Nov; 5(1):15-25. PubMed ID: 6659333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants.
    Stills HF
    ILAR J; 2005; 46(3):280-93. PubMed ID: 15953835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of several adjuvants as alternatives to the use of Freund's adjuvant in rabbits.
    Leenaars PP; Hendriksen CF; Angulo AF; Koedam MA; Claassen E
    Vet Immunol Immunopathol; 1994 Mar; 40(3):225-41. PubMed ID: 8160361
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Macrophage interleukin 1 response to injected silicone in a rat model.
    Das SK; Johnson M; Ellsaesser C; Brantley SK; Kanosky MG; Johnson SG
    Ann Plast Surg; 1992 Jun; 28(6):535-7. PubMed ID: 1622034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suppression of IgE antibody formation in mice with nonspecific stimulation.
    Itaya T; Tomioka H; Kumagai A; Tada T
    Int Arch Allergy Appl Immunol; 1980; 62(4):389-96. PubMed ID: 7380577
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants.
    Yang CW; Strong BS; Miller MJ; Unanue ER
    J Immunol; 2010 Sep; 185(5):2927-34. PubMed ID: 20679530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.